Tattooing, which involves the placement of ink into the skin, is an ancient decorative technique that has remained popular in modern society. Tattoos have long been known to cause cutaneous reactions, which include the emergence of neoplasms such as keratoacanthoma (KA) and squamous cell carcinoma (SCC) in tattooed areas of the skin. We review the clinical presentations, histology and treatment options for squamous neoplasms, primarily KA and SCC, arising in tattoos.
Introduction
Tattooing is a well-known ancient artistic practice characterized by the intradermal placement of pigment, and it has increased in popularity over the past 20 years. 1, 2 This practice may be performed for aesthetic, religious or cultural reasons. 1 In the US, the prevalence of at least one tattoo is estimated at approximately 24% in the 18-50 years age group. 2 Tattooing is also a popular practice in European countries as well, with prevalences ranging from 8.5% to 25% of the population, depending on the individual country and/or age group. 3, 4 Several types of cutaneous reactions have been observed within tattoos, including verruca, mycobacterial infections, allergic contact dermatitis, localized inflammation, sarcoidosis, foreign body granulomas, keloids, generalized inflammatory skin eruptions and malignancies. 5, 6 In a survey performed in Germany in 2010, 6% of participants reported adverse reactions after tattooing. 3 Tattoo inks and pigments are not regularly monitored by the United States Food and Drug Administration (FDA). Additionally, concerns have been raised for many years regarding tattoos and their possible association with neoplasms. A review of the literature performed in 2012 revealed 50 cases of skin malignancy occurring in tattoos, 16 of which were melanomas and 11 of which were basal cell carcinomas (BCCs).
7 Keratoacanthoma (KA) and squamous cell carcinoma (SCC) were the most commonly reported neoplasms, with 23 reported cases identified in the literature. 7 McQuarrie reported the first case of SCC arising in a tattoo in 1966. 8 Closely thereafter, Cipollaro reported a case of KA within a tattoo. 9 More recently, Barton et al. 10 reported a case of multiple eruptive KAs on the lips after tattoo placement.
We reviewed the literature on the clinical presentation, histopathology and treatment of squamous neoplasms, particularly KA and SCC, arising within tattoos.
Clinical presentation
In this review, we found 24 reported cases of squamous neoplasms arising within tattoos (Table 1) . 5, [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] These lesions often present as an enlarging, erythematous papule or nodule that may have associated ulceration, scale, induration, or central keratinaceous material. 1, 5, 8, 13, 15, 21 Solitary nodules are most common, but multiple lesions at initial presentation or developing over time have also been described. 1, 11, 15, 18 This phenomenon has been reported to occur in patients with ages ranging from 24 to 79 years. 9, 17 The age of the tattoo at the time of presentation may vary from weeks to > 50 years after tattoo placement. 14, 17 The majority of the reported cases were seen in men (15 men, 8 women, 2 sex unknown), and lesions were primarily located on the extremities. 5, 8, 9, 11, 12, [15] [16] [17] [18] [19] 21 Eruption of KA or SCC within tattoos demonstrates a preference for those drawn in red ink, but may also be seen with black pigment and multicolour tattoos. Red pigment has long been known to be associated with tattoo reactions. 1 Mercuric sulphide, a common component of red ink, has been considered a possible cause of tattoo reactions; however, these complications have also been reported within red area of tattoos that have used alternative agents. 22 Red tattoos are the most commonly reported in association with KA and SCC, with up to 82% of cases in some series, and 64% in our previous report. 1 
Diagnosis
The differential diagnoses of KAs and SCCs arising within tattoos may include inflammation immediately following ink application, allergic contact dermatitis, hypersensitivity, foreign body reactions, pseudolymphomatous reactions, pseudoepitheliomatous hyperplasia, sarcoidosis, lichenoid reactions, bacterial, viral or fungal infeciton, malignant melanoma, BCC, dermatofibrosarcoma protuberans, and squamous neoplasms such as KA and SCC. 23 Clinical morphology may be helpful, as a rapidly growing crateriform lesion may be suggestive of KA. Tenderness may be indicative of malignancy or infection, while pruritus may suggest a contact dermatitis or hypersensitivity. Therefore, the patient should be thoroughly interviewed for associated symptoms in order to further narrow the differential diagnosis. Histology is considered the gold standard to confirm diagnosis. Skin biopsy including punch, shave or excisional biopsy should be performed. Cultures should also be obtained when appropriate if infection is suspected. 14, 17, 20, 23, 24 
Histopathology
The histopathological similarities and differentiation of atypical squamous proliferations has been debated in the literature, making the distinction in reports more difficult. In the 24 reports in the literature, KA was the most commonly reported squamous neoplasm (15/ 24), while SCC made up the remaining diagnoses: three well-differentiated SCCs, one poorly differentiated SCC, five SCCs with KA features, one SCC with cystic and KA features, and one SCC with verrucous features.
In two cases, both SCC and KA were reported. 1, 10, 13, 14 This variability in diagnosis highlights the histopathological similarity of KA and SCC, and the debate about whether these lesions are separate entities or represent a spectrum of the same disease. To highlight this difficulty, Fraga and Prossick retrospectively reviewed 11 specimens from 8 patients, and reclassified four diagnoses of well-differentiated SCC as KA, and two cases of pseudoepitheliomatous hyperplasia as KA. 12 Formation of cutaneous malignancies within tattoos is hypothesized to occur secondary to multiple inciting factors, including trauma arising from the tattooing procedure, tattoo-induced scarring, a chronic inflammatory reaction to the pigmentation, potential carcinogenesis from the pigment and potential exacerbation from ultraviolet exposure if the tattoo is in a sun-exposed site. 7, 20, 25 Trauma appears to be more strongly related to neoplasm development, as demonstrated by rapid development of a KA shortly after the procedure, resulting from cellular hyperplasia and localized inflammation. 18 The transepidermal elimination of tattoo pigment observed in some cases suggests a local immune response attempting to remove the pigmentation, and may suggest KA is the result of a reactive rather than neoplastic process. 18 The chronic inflammation that occurs after tattoo placement is thought to be more strongly associated with development of SCC. 25 It may be possible to differentiate the squamous proliferations based upon time of development; those that develop within a year of the tattooing procedure most likely represent KA, whereas those that develop years later secondary to chronic inflammation are most likely SCC.
Treatment
Review of the literature demonstrated that surgical excision is the most common method of treatment, with no reports of recurrence to date. Mohs micrographic surgery has also been used, notably on the calf and lip, where tissue conservation may be considered critical. 14, 15, 19 Vitiello et al. 18 reported a case of multiple eruptive KAs within a tattoo managed with acitretin; lesions were decreased in size after 4 weeks of treatment. Fraga and Prossick reported one regressing KA that appeared to be resolved post biopsy, and was therefore monitored clinically. Other approaches such as intralesional therapy with methotrexate, 5-fluorouracil (5-FU), bleomycin, interferon-alfa and systemic retinoids, have been used to treat KA with success, but no reports of these methods used for KA within tattoos are available.
Conclusion
Squamous neoplasms arising in tattoos, particularly KA and SCC, are an unusual phenomenon, with few reports in the literature. Although the true incidence of such neoplasms is unclear, they should be included in the list of potential cutaneous complications related to tattooing. A direct association between tattoos and cutaneous neoplasms has not been established, but the International Agency for Research on Cancer has classified some common ingredients of tattoo ink as possibly carcinogenic (e.g. mercury, carbon black and cobalt sulphate) and carcinogenic to humans (e.g. cadmium compounds). 7 Considering the number of tattooed individuals worldwide and the small number of reported skin malignancies arising within tattoos, this phenomenon is considered by some to be coincidental. However, it is possible that cases may be underreported. Neoplasms are not included as a possible side effect of tattoo application within the online FDA consumer resources. 27 Further research is needed to determine whether there is a true association.
Learning points
• Tattooing can lead to various cutaneous complications, including the development of squamous neoplasms.
• Histopathological evaluation should be performed in all tumours arising within a tattoo.
• Commonly diagnosed squamous neoplasms within tattoos include KA and SCC.
• Based on review of the literature, red is the ink colour most commonly associated with squamous neoplasms.
